Alexey L. Margolin, Chief Scientific Officer at Altus Pharmaceuticals Inc. (ALTU), sold 1,100 shares at $16.71 ($18K) on 2006-11-13, disclosed to the SEC on 2006-11-15.
Open-market sale of $18k ALTU by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.60 | 100 | $2K | 9.0% |
| 2 | $16.67 | 300 | $5K | 27.3% |
| 3 | $16.68 | 200 | $3K | 18.2% |
| 4 | $16.69 | 200 | $3K | 18.2% |
| 5 | $16.70 | 100 | $2K | 9.1% |
| 6 | $16.71 | 200 |
| $3K |
| 18.2% |
| Total | $16.68 avg | 1,100 | $18K | 100% |
| Filing → |
| ALTU | SELL | 2007-03-26 | $50K | — | Filing → |
| ALTU | SELL | 2007-03-19 | $47K | — | Filing → |
| ALTU | SELL | 2007-03-06 | $44K | — | Filing → |